Dow Up 0.12% Nasdaq Up 0.56%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
2.98 Up 0.03(1.02%) 10:29AM EST - Nasdaq Real Time Price
Prev Close:2.95
Open:2.93
Bid:2.95 x 3000
Ask:2.99 x 200
1y Target Est:9.00
Beta:0.39
Next Earnings Date:N/A
Day's Range:2.93 - 2.99
52wk Range:2.68 - 5.25
Volume:1,212
Avg Vol (3m):101,551
Market Cap:68.47M
P/E (ttm):N/A
EPS (ttm):-0.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCUp 1.02%68.47M
AZNDown 0.59%93.61B
JNJDown 0.57%300.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Dec-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback